Acacia Res-Acacia (ACTG) 5.41 $ACTG Acacia Research

New Post Public Reply Private Reply Replies (0) Message Board

Jul 31, 2016 at 10:06 PM

Acacia Res-Acacia (ACTG) 5.41 $ACTG

Acacia Research Reports Second Quarter Financial Results
BusinessWire - Thu Jul 28, 3:00PM CDT
Acacia Research Corporation(1) (Nasdaq: ACTG) today reported results for the three months ended June 30, 2016.
ACTG: 5.41 (+0.32)

Acacia Subsidiary Signs Settlement and Patent License Agreement with American Gem Society and American Gem Society Laboratories, LLC
BusinessWire - Mon Jun 20, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Diamond Grading Technologies, LLC. subsidiary has signed a settlement and patent license agreement with American Gem Society and American Gem Society Laboratories, LLC. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 5.41 (+0.32)

Acacia Research Has Returned 29.9% Since SmarTrend Recommendation (ACTG)
Comtex SmarTrend(R) - Tue Jun 07, 1:37PM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 3 months, Acacia Research has returned 29.89% as of today's recent price of $5.17.
ACTG: 5.41 (+0.32)

Uptrend Call Working As Acacia Research Stock Rises 31.4% (ACTG)
Comtex SmarTrend(R) - Tue May 31, 12:56AM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 2 months, Acacia Research has returned 31.41% as of today's recent price of $5.23.
ACTG: 5.41 (+0.32)

Acacia Research (ACTG) is in Overbought Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:17AM CDT
Acacia Research Corporation (ACTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
ACTG: 5.41 (+0.32)

Upgrade Alert for Acacia Research (ACTG)
Comtex SmarTrend(R) - Tue May 24, 3:01AM CDT
Acacia Research (NASDAQ:ACTG) was upgraded from Market Perform to Outperform at Northland today. The stock closed yesterday at $5.08 on volume of 613,000 shares, above average daily volume of 505,000. In the past 52 weeks, shares of Acacia Research have traded between a low of $2.82 and a high of $10.86 and closed yesterday at $5.08, which is 80% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1.3% while the 50-day MA has advanced 1.7%.
ACTG: 5.41 (+0.32)

Uptrend Call Working As Acacia Research Stock Rises 26.8% (ACTG)
Comtex SmarTrend(R) - Mon May 23, 1:12PM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 2 months, Acacia Research has returned 26.76% as of today's recent price of $5.05.
ACTG: 5.41 (+0.32)

Acacia Research (ACTG) is Overbought: Is A Drop Coming?
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:50AM CDT
Acacia Research Corp (ACTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company
ACTG: 5.41 (+0.32)

Xerox (XRX) Misses on Q1 Earnings, Split Likely in 2016
Supriyo Bose - Zacks Investment Research - Mon Apr 25, 9:39AM CDT
Xerox Corporation (XRX) reported relatively modest first-quarter 2016 results with adjusted earnings (from continuing operations) of 22 cents per share compared with 24 cents in the year-ago quarter.
PFMT: 2.10 (+0.06), ACTG: 5.41 (+0.32), XRX: 10.30 (+0.39), PFSW: 9.91 (-0.18)

Acacia Research reports 1Q loss
Automated Insights - Thu Apr 21, 3:21PM CDT
NEWPORT BEACH, Calif. (AP) _ Acacia Research Corp. (ACTG) on Thursday reported a loss of $10 million in its first quarter.
ACTG: 5.41 (+0.32)

Acacia Research Reports First Quarter Financial Results
BusinessWire - Thu Apr 21, 3:00PM CDT
Acacia Research Corporation(1) (Nasdaq: ACTG) today reported results for the three months ended March 31, 2016.
ACTG: 5.41 (+0.32)

Domtar Provides Sneak Peek into First-Quarter 2016 Results
Zacks Equity Research - Zacks Investment Research - Mon Apr 18, 1:19PM CDT
Domtar Corporation (UFS), a leading fiber-based technology company, recently provided an update on its first quarter 2016 financial performance.
ACTG: 5.41 (+0.32), UFS: 39.37 (-0.16), FBR: 6.15 (-0.13)

Healthcare Services Q1 Earnings in Line, Dividend Raised
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 9:00AM CDT
Healthcare Services Group, Inc. (HCSG) reported first-quarter 2016 net income of 26 cents per share, in line with the Zacks Consensus Estimate.
VEC: 31.15 (+0.33), ACTG: 5.41 (+0.32), PRGX: 4.75 (-0.01), HCSG: 38.81 (-0.27)

What Falling Estimates & Price Mean for Everi Holdings (EVRI)
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 8:07AM CDT
Everi Holdings has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off
ACTG: 5.41 (+0.32), EVRI: 1.90 (+0.02)

Ocean Tomo Announces Completion of over $650 Million in Intellectual Property Transaction Volume
PRWeb - Tue Apr 12, 3:46PM CDT
Ocean Tomo, LLC, the intellectual capital merchant banc™ firm, announced today updated performance of the Ocean Tomo Transactions Business Unit. Ocean Tomo has served as a trusted advisor to both large and small operating company patent owners, successfully closing a number of transactions with cumulative transaction value in excess of $650 million.
ACTG: 5.41 (+0.32)

Acacia Research Names Frank E. Walsh, III to Its Board of Directors
BusinessWire - Thu Apr 07, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that Frank E. Walsh, III has joined its Board of Directors.
ACTG: 5.41 (+0.32), FCCY: 12.50 (-0.04)

US Ecology (ECOL) to Divest Non-Core Asset USE Augusta
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 2:30PM CDT
US Ecology, Inc. (ECOL), a renowned North American firm, recently announced the strategic sale of its non-hazardous solid and liquid waste processing unit, USE Augusta
CBZ: 10.81 (-0.16), ECOL: 45.30 (-2.70), ACTG: 5.41 (+0.32), WM: 66.12 (-0.24)

Acacia Research to Release First Quarter Financial Results and Host Conference Call
BusinessWire - Wed Apr 06, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its first quarter financial results on Thursday, April 21, 2016. Results will be released at 4:00 PM (EDT) / 1:00 PM (PDT).
ACTG: 5.41 (+0.32)

The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 8:30AM CDT
The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
REGI: 9.75 (+0.37), ACTG: 5.41 (+0.32), CAMP: 14.20 (-0.18), SCMP: 11.75 (+0.07)

Acacia Subsidiary Signs Patent License Agreement with Ericsson Inc. and Telefonaktiebolaget LM Ericsson
BusinessWire - Fri Apr 01, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Adaptix, Inc. subsidiary has signed a patent license agreement with Ericsson, Inc. and Telefonaktiebolaget LM Ericsson. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 5.41 (+0.32)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Canada and Ukraine Fortify Defense with UGV Partnership

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Special Needs Group Partners with MAST to Enhance Accessibility

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Trial for Former OB/GYN Arthur Park Begins in Bakersfield

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

AtWork Welcomes Franchise Vet Sarah Goehring

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Laars Welcomes Women in Manufacturing to Facility Tour

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Dr. Anderson’s Journey: Leadership with Faith and Service

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

Franco-Nevada's Q3 Results Loom: Investors Ready

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...